Literature DB >> 9298438

Identification of Beck Depression Inventory items related to multiple sclerosis.

D C Mohr1, D E Goodkin, W Likosky, L Beutler, N Gatto, M K Langan.   

Abstract

The percentage contribution of each item on the Beck Depression Inventory (BDI) to the total BDI score was compared across patients with multiple sclerosis (MS), patients diagnosed with major depressive disorder, and normal college students. We considered an item to be confounded by MS-related symptoms if its percentage contribution to the total BDI score was significantly greater in the MS group than the major depression and control groups. Items measuring work difficulty, fatigue, and concerns about health met this criterion. These items accounted for 34, 17, and 19% of the total BDI score in the MS, major depression, and control groups, respectively. Using the 18-item BDI (BDI-18) which resulted from excluding the 3 confounded items, MS patients found to be were more depressed than controls but less depressed than the major depression group. The identification of signs of depression not confounded with MS which could be substituted for confounded signs was also discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9298438     DOI: 10.1023/a:1025573315492

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  16 in total

1.  Predictors of differential response to cognitive, experiential, and self-directed psychotherapeutic procedures.

Authors:  L E Beutler; D Engle; D Mohr; R J Daldrup; J Bergan; K Meredith; W Merry
Journal:  J Consult Clin Psychol       Date:  1991-04

2.  Revised estimate of the prevalence of multiple sclerosis in the United States.

Authors:  D W Anderson; J H Ellenberg; C M Leventhal; S C Reingold; M Rodriguez; D H Silberberg
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

3.  Sleep disturbance, depression, and lesion site in patients with multiple sclerosis.

Authors:  C M Clark; J A Fleming; D Li; J Oger; H Klonoff; D Paty
Journal:  Arch Neurol       Date:  1992-06

Review 4.  Affective disorders in multiple sclerosis. Review and recommendations for clinical research.

Authors:  S L Minden; R B Schiffer
Journal:  Arch Neurol       Date:  1990-01

5.  Mood disturbance versus other symptoms of depression in multiple sclerosis.

Authors:  D L Nyenhuis; S M Rao; J M Zajecka; T Luchetta; L Bernardin; D C Garron
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

6.  Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment.

Authors:  D C Mohr; D E Goodkin; W Likosky; N Gatto; L K Neilley; C Griffin; B Stiebling
Journal:  Mult Scler       Date:  1996-12       Impact factor: 6.312

7.  Measurement of depression in patients with cancer.

Authors:  J Endicott
Journal:  Cancer       Date:  1984-05-15       Impact factor: 6.860

8.  Increased depression in multiple sclerosis patients. A meta-analysis.

Authors:  D S Schubert; R H Foliart
Journal:  Psychosomatics       Date:  1993 Mar-Apr       Impact factor: 2.386

9.  Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis.

Authors:  R A Rudick; D Miller; J D Clough; L A Gragg; R G Farmer
Journal:  Arch Neurol       Date:  1992-12

10.  Differentiation between somatic and cognitive/affective components in commonly used measurements of depression in patients with chronic low-back pain. Let's not mix apples and oranges.

Authors:  A L Wesley; R J Gatchel; P B Polatin; R K Kinney; T G Mayer
Journal:  Spine (Phila Pa 1976)       Date:  1991-06       Impact factor: 3.468

View more
  25 in total

1.  Optimism and adaptation to multiple sclerosis: what does optimism mean?

Authors:  M Fournier; D de Ridder; J Bensing
Journal:  J Behav Med       Date:  1999-08

Review 2.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 3.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

4.  A tutorial on structural equation modeling for analysis of overlapping symptoms in co-occurring conditions using MPlus.

Authors:  Douglas D Gunzler; Nathan Morris
Journal:  Stat Med       Date:  2015-06-04       Impact factor: 2.373

5.  Factors that contribute to quality of life outcomes prioritised by people with multiple sclerosis.

Authors:  Maggie Somerset; Tim J Peters; Deborah J Sharp; Rona Campbell
Journal:  Qual Life Res       Date:  2003-02       Impact factor: 4.147

6.  The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis.

Authors:  Patricia J Moran; David C Mohr
Journal:  J Behav Med       Date:  2005-02

7.  High concurrent presence of disability in multiple sclerosis. Associations with perceived health.

Authors:  Sverker Johansson; Charlotte Ytterberg; Ingrid M Claesson; Jenny Lindberg; Jan Hillert; Magnus Andersson; Lotta Widén Holmqvist; Lena von Koch
Journal:  J Neurol       Date:  2007-04-02       Impact factor: 4.849

8.  A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis.

Authors:  J E Aikens; J S Fischer; M Namey; R A Rudick
Journal:  J Behav Med       Date:  1997-10

9.  Screening Tools for Anxiety in People with Multiple Sclerosis: A Systematic Review.

Authors:  Brittany Litster; Kirsten M Fiest; Scott B Patten; John D Fisk; John R Walker; Lesley A Graff; James M Bolton; Jitender Sareen; James J Marriott; Lindsay I Berrigan; Charles N Bernstein; Ryan Zarychanski; Alexander Singer; Carol A Hitchon; Christine A Peschken; Ruth Ann Marrie
Journal:  Int J MS Care       Date:  2016 Nov-Dec

10.  Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.

Authors:  Douglas D Gunzler; Adam Perzynski; Nathan Morris; Robert Bermel; Steven Lewis; Deborah Miller
Journal:  J Behav Med       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.